Presence of functional dendritic cells in patients chronically infected with hepatitis C virus

Randy S Longman1, Andrew H Talal, Ira M Jacobson

  • 1Institut Pasteur, 25, Rue du Dr ROUX, Paris, France 75724. albertm@pasteur.fr

Blood
|October 4, 2003
PubMed

Insights

Dendritic cells (DCs) in chronic hepatitis C virus (HCV) patients are not impaired. These mature DCs can prime T cells, suggesting the immune deficit is specific to HCV, not a general DC dysfunction.

Area of Science:

  • Immunology
  • Virology
  • Cell Biology

Background:

  • Chronic hepatitis C virus (HCV) infection is associated with a lack of HCV-reactive CD8(+) T lymphocytes (CTLs).
  • Previous studies suggested impaired dendritic cell (DC) function in chronic HCV patients, potentially explaining the CTL defect.
  • This contrasts with the known immune competence of chronic HCV patients, necessitating a re-evaluation of DC function.

Purpose of the Study:

  • To re-evaluate the function and phenotype of dendritic cells (DCs) in patients with chronic hepatitis C virus (HCV) infection.
  • To compare DC function and maturation markers in HCV-infected individuals with non-infected controls.
  • To clarify the role of DCs in the context of HCV-specific immune deficits.

Main Methods:

  • Phenotypic analysis of dendritic cells (DCs) from chronic hepatitis C virus (HCV) patients and healthy controls.
  • Assessment of the functional capacity of patient-derived DCs to prime allogeneic T lymphocytes.
  • Evaluation of DC ability to stimulate influenza-specific memory T cells.

Main Results:

  • Dendritic cells (DCs) from all 13 chronic hepatitis C virus (HCV) patients examined displayed typical maturation markers.
  • These mature DCs demonstrated the capacity to effectively prime allogeneic T lymphocytes.
  • The DCs were also capable of stimulating influenza-specific memory T cells, indicating preserved general immune function.

Conclusions:

  • Contrary to previous findings, dendritic cells (DCs) in chronic hepatitis C virus (HCV) patients exhibit normal maturation and function.
  • The observed immune deficit in chronic HCV appears to be specific to the virus rather than a generalized DC impairment.
  • Further research is needed to develop refined models for understanding the role of DCs in HCV pathogenesis and immune response.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...